UgHerald provides the most timely and comprehensive news coverage of Uganda. It covers a wide range of fields including politics, economy, society, culture, sports, as well as in-depth analysis of international relations and important domestic events. Whether you are concerned about local developments or international influences, this is the best source for the latest information on Uganda. We are committed to helping readers understand the current situation and future of Uganda through accurate, objective and in-depth news reports, while paying attention to the challenges and development opportunities it faces.

About Us

tanzania times : Latest News and In-depth Analysis
Contact Us

Travel

HomeTravel

All News

Jan 14, 2025

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.

Jan 14, 2025

DASI, LLC appoints new President as it continues to drive growth and strengthen leadership in the Aviation Aftermarket

Industry veteran Mike Heaton takes the helm to accelerate innovation and further enhance DASI,LLC\'s market position

Jan 14, 2025

The Industry's First Cloud-Free Disposable is Coming: NEXA ULTRA InvisaCloud Edition

Jan 13, 2025

Future Minerals Forum to Announce Major Agreements Worth Billions

RIYADH,Saudi Arabia,Jan. 11,2025-- The highly anticipated fourth edition of the Future Minerals Forum,set to take place from January 14 to 16,2025,in Riyadh,is set to announce big agreements worth bi

Jan 13, 2025

Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited

HONG KONG,Jan. 11,2025-- Dunxin Financial Holdings("DXF" or the "Company") (OTC Pink: DXFFY,DXFFD)is pleased to announce that effective on January10,2025,the Company will change it

Jan 13, 2025

Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity

Regor announced its 12-week single-dose Phase 2a trial results for RGT-075,a once-daily oral GLP-1RA,reporting 5% placebo-adjusted weight-loss with no plateau

1 ... 101 102 103 104 105 106 107 ... 109